Replies to post #440147 on NorthWest Biotherapeutics Inc (NWBO)

[hoffmann6383]

Thanks for the response senti.

[flipper44]

It’s your opinion. You guessed at two critical points. So you don’t know. Know what I mean?

There is a huge flaw in your theory. One that could hurt DCVax-l if you were correct and at best, be risky.

BTW, do you know which pharma ran the most SOC trials? My guess is you do and intentionally avoided their name. It rhymes with perk.

[dennisdave]

absolutely no surprise in what you are saying


I'm going to ask and say it again.

I believe NWBO will exclude IDH mutant from its data for future GBM trial comparison. There is no law that would withhold NWBO to showcase the data ex IDH-mutant without comparing it to anything but very helpful for future GBM trials now in phase 1 or 2 to compare it with.

Would you not agree?